Propel(x) Company Profile

09:59 EST 27th January 2020 | BioPortfolio

Propel(x) Inc. is an online investment platform that connects deep technology startups with angel investors, and features startups in the life sciences, energy & clean technology, computer sciences, new materials and space sectors. Propel(x) was founded in 2013 by CEO, Swati Chaturvedi and Lisheng Wang, who also founded the MIT Alumni Angels. Through its community-centric diligence processes, Propel(x) demystifies investing in deep technology and removes the funding barriers for these startups. For more information, please visit:

News Articles [33 Associated News Articles listed on BioPortfolio]

Intersect ENT gets FDA approval new PROPEL mini straight delivery system

PROPEL Mini helps maintain the sinus opening while delivering mometasone furoate directly where it is needed, improving outcomes of frontal (behind the forehead) and ethmoid (behind the bridge The po...

Surges in R&D Jobs, VC Propel Massachusetts Biopharma Growth

Surges in R&D jobs and venture capital investment kept Massachusetts’ top-tier biopharma cluster growing last year, according to the latest edition of the annual report from the state’s life ...

Surges in R&D Jobs, VC Propel #Massachusetts Biopharma Growth: …

Surges in R&D Jobs, VC Propel #Massachusetts Biopharma Growth: …

$60M B round to propel Landos through Phase II IBD trials

Surges in R&D Jobs, VC Propel #Massachusetts Biopharma Growth:

Surges in R&D Jobs, VC Propel #Massachusetts Biopharma Growth:

Surges in R&D Jobs, VC Propel #Massachusetts Biopharma Growth:

Surges in R&D Jobs, VC Propel #Massachusetts Biopharma Growth:

Surges in R&D Jobs, VC Propel #Massachusetts Biopharma Growth:

Surges in R&D Jobs, VC Propel #Massachusetts Biopharma Growth:

Technology can propel healthcare out of the Middle Ages     

Engineers today are developing extraordinary abilities to understand and intervene with physiology    

Drugs and Medications [0 Results]


PubMed Articles [22 Associated PubMed Articles listed on BioPortfolio]

Iron-Exchanged Zeolite Micromotors for Enhanced Degradation of Organic Pollutants.

Self-propelled iron-exchanged zeolite (Fe-zeolite) micromotors have been developed for efficient degradation of organic pollutants via Fenton-like reaction. The incorporation of iron ions into the zeo...

Promotion of Regular Oesophageal Motility to Prevent Regurgitation and Enhance Nutrition Intake in Long-Stay ICU Patients. A Multicenter, Phase II, Sham-Controlled, Randomized Trial: The PROPEL Study.

To evaluate the effect of esophageal stimulation on nutritional adequacy in critically ill patients at risk for enteral feeding intolerance.

Public Understanding and Opinions regarding Genetic Research on Alzheimer's Disease.

Participants willing to provide genetic samples are needed to propel research on Alzheimer's disease (AD) treatment and prevention forward. A limited public understanding of what AD genetic research e...

Transitioning From Volume to Value: Lessons Learned From the Dissolution of a Population Health Partnership.

In 2017, the authors published an article describing the experiences of Oregon Health & Science University (OHSU) as it adapted to new challenges of changing payment models, the imperative to manage t...

Integrating nanomedicine into clinical radiotherapy regimens.

While the advancement of clinical radiotherapy was driven by technological innovations throughout the 20th century, continued improvement relies on rational combination therapies derived from biologic...

Clinical Trials [16 Associated Clinical Trials listed on BioPortfolio]

Propel Stent vs Kenalog-soaked Nasopore After Frontal Drill-out

Surgery on the frontal sinus is done for patients who have sinus problems that do not respond to medications. It involves making an opening within the right and left frontal sinus of the n...

The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery

Report on the technical feasibility and outcomes of in-office placement of PROPEL or PROPEL mini implants immediately following ethmoid sinus surgery

PROPEL Randomized Trial

It is important for people with stroke to exercise in order to improve their overall recovery and general health. However, these individuals are less physically active than people without ...

(PROGRESS) Safety and Efficacy of the Propel Mini Steroid-Eluting Sinus Implant in Frontal Sinus

The objective of the PROGRESS Study is to assess the safety and efficacy of the Propel Mini steroid-eluting Sinus Implant when placed in the frontal sinus opening following frontal sinus s...

A Clinical Evaluation of Propel Mini Sinus Implant Placement in the Frontal Sinus Ostia Following In-office Dilation

A prospective, randomized, single-blind, intra-patient controlled, multicenter study. Study subjects will undergo implant placement on one side following in-office balloon dilation, while ...

Companies [17 Associated Companies listed on BioPortfolio]

Propel Technology

PROPEL is a group of programs aimed at increasing the number and success rate of early-stage life sciences companies in Illinois. PROPEL helps guide the development of formation-s...


Propel(x) Inc. is an online investment platform that connects deep technology startups with angel investors, and features startups in the life sciences, energy & clean technology,...

Propel Orthodontics

Propel is a leading innovator, manufacturer and worldwide seller of orthodontic devices with offices in Ossining, New York, and Milpitas, California in the heart of Silicon Valley...

Intersect ENT, Inc. '

Intersect ENT, Inc. is dedicated to improving the quality of life for patients with ear, nose and throat conditions. The company markets two steroid releasing implants, PROPEL and...


AlayaCare is an award-winning provider of revolutionary cloud-based home healthcare software. With a product spanning clinical documentation, back office functionality, client and...

More Information about "Propel(x)" on BioPortfolio

We have published hundreds of Propel(x) news stories on BioPortfolio along with dozens of Propel(x) Clinical Trials and PubMed Articles about Propel(x) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Propel(x) Companies in our database. You can also find out about relevant Propel(x) Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record